Huntington National Bank’s SpringWorks Therapeutics SWTX Stock Holding History

Huntington National Bank’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47	Hold	1	–	–	﹤0.01%	3130
2026 Q1	$47	Hold	1	–	–	﹤0.01%	2946
2025 Q4	$47	Hold	1	–	–	﹤0.01%	2864
2025 Q3	$47	Sell	1 -442	-100%	-$20.8K	﹤0.01%	2933
2025 Q2	$20.8K	Buy	443 +16	+4%	+$712	﹤0.01%	1556
2025 Q1	$18.8K	Sell	427 -267	-38%	-$12.3K	﹤0.01%	1539
2024 Q4	$25.1K	Buy	694 +192	+38%	+$6.71K	﹤0.01%	1473
2024 Q3	$16.1K	Sell	502 -10	-2%	-$374	﹤0.01%	1584
2024 Q2	$19.3K	Buy	+512	New	+$21.6K	﹤0.01%	1469

Huntington National Bank's SWTX Position: Q2 2026 in Review

Huntington National Bank held its SpringWorks Therapeutics (SWTX) position steady in Q2 2026 at 1 share worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

Huntington National Bank first reported a position in SWTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $25.1K in Q4 2024. 1 fund tracked by Wall St. Rank holds SWTX as of Q2 2026.

Huntington National Bank held 1 share of SpringWorks Therapeutics worth $47 as of Q2 2026.
Huntington National Bank left its SpringWorks Therapeutics share count unchanged in Q2 2026.
SpringWorks Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #3130 holding.
Huntington National Bank first reported a position in SpringWorks Therapeutics in Q2 2024 and has held it in 9 quarters since.
Huntington National Bank's SpringWorks Therapeutics position peaked at $25.1K in Q4 2024.
1 fund tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.